Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Sang

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|March 21, 2022
[Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome]Ya Gao, Xin Chen, Zhen Zhang, et al.
The British Journal of Dermatology|November 4, 2025
Excessive Glycine Loop Variations in the Keratin 10 Tail Domain and Implications for Skin FragilityZihao Mi, Yueqian Yu, Zhenzhen Wang, et al.
Cancer Cell International|November 11, 2025
Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasmMeng Wang, Xiaotong Xue, Zhenzhen Wang, et al.
Pathology Oncology Research : POR|July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia CellsKunlong Zhang, Li Gao, Jianwei Wang, et al.
Journal of Immunology Research|September 28, 2023
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1Kunlong Zhang, Jun Lu, Fang Fang, et al.
Cancer Biology & Therapy|September 28, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genesLi Ma, Jianwei Wang, Yongping Zhang, et al.
Journal of Immunology Research|August 12, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid LeukemiaXu Sang, Yongping Zhang, Fang Fang, et al.
Hematology (Amsterdam, Netherlands)|August 18, 2023
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3Li Ma, Jianwei Wang, Yang Yang, et al.
Cell Death & Disease|August 12, 2023
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1Lihui Lu, Jianwei Wang, Fang Fang, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 16, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemiaFang Fang, Jun Lu, Xu Sang, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|March 21, 2022
[Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome]Ya Gao, Xin Chen, Zhen Zhang, et al.
The British Journal of Dermatology|November 4, 2025
Excessive Glycine Loop Variations in the Keratin 10 Tail Domain and Implications for Skin FragilityZihao Mi, Yueqian Yu, Zhenzhen Wang, et al.
Cancer Cell International|November 11, 2025
Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasmMeng Wang, Xiaotong Xue, Zhenzhen Wang, et al.
Pathology Oncology Research : POR|July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia CellsKunlong Zhang, Li Gao, Jianwei Wang, et al.
Journal of Immunology Research|September 28, 2023
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1Kunlong Zhang, Jun Lu, Fang Fang, et al.
Cancer Biology & Therapy|September 28, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genesLi Ma, Jianwei Wang, Yongping Zhang, et al.
Journal of Immunology Research|August 12, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid LeukemiaXu Sang, Yongping Zhang, Fang Fang, et al.
Hematology (Amsterdam, Netherlands)|August 18, 2023
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3Li Ma, Jianwei Wang, Yang Yang, et al.
Cell Death & Disease|August 12, 2023
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1Lihui Lu, Jianwei Wang, Fang Fang, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 16, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemiaFang Fang, Jun Lu, Xu Sang, et al.
Pageof 3